Vehicle for Rectal Administration of Indomethacin.
Pharmaceutical Research, 1989. 6(4): p. 338–341.
18. Morimoto, K., et al., Evaluation of Polyvinyl Alcohol Hydrogel as Sustained-Release
Vehicle
PRMT1 P6996 3276 PRMT1 P NP_001527.3 y y y
340 Heat Shock Factor 1 H4163 3297 HSF1 P NP_005517.1 y y y
341 Heat Shock Factor 2 H6788 3298 HSF2 P NP_001129036.1 y n/d y
345 Heat Shock Protein 70
PRMT1 P6996 3276 PRMT1 P NP_001527.3 y y y
340 Heat Shock Factor 1 H4163 3297 HSF1 P NP_005517.1 y y y
341 Heat Shock Factor 2 H6788 3298 HSF2 P NP_001129036.1 y n/d y
345 Heat Shock Protein 70
PRMT1 P6996 3276 PRMT1 P NP_001527.3 y y y
340 Heat Shock Factor 1 H4163 3297 HSF1 P NP_005517.1 y y y
341 Heat Shock Factor 2 H6788 3298 HSF2 P NP_001129036.1 y n/d y
345 Heat Shock Protein 70
100 µL 04-341
Anti-phospho-EGFR (Tyr1173) 9H2 H M IP WB FC IF M IgG1k 50 µg 05-483
Anti-EGFR (non-phospho-Tyr1173) 20G3 H M IP WB M IgG1κ 50 µg 05-484
Anti-Epidermal Growth Factor 144-8 H M IP IH
335 HDAC-8 H6412 M y n/d n/d
336 Anti Cy3+Cy5 C0992 M NA NA NA
337 HDAC-10 H3413 P y y y
338 HDAC-11 H2913 M y n/d n/d
339 HDRP/MITR H9163 P y y n/d
340 Heat Shock Factor 1 H4163 P y y
Akt1/PKBα (δPH, S473D), active KA 10 µg 14-453
Akt1/PKBα, (PHD deletion), active KA 10 µg 14-341
Akt1/PKBα , PH Domain (aa 1-149) PIA 100 µg 14-245
Description Clone Species Applications Format
Heat Shock Factor 1 H4163 79245, 15499, 3297 HSF1,Hsf1 XP_001075095.1,NP_032322.1,NP_005517.1 P y y y
341 Heat Shock Factor 2 H6788 64441, 3298, 15500 HSF2,Hsf2 NP_113882.1,NP_004497.1,NP_032323.2 P y n/d
Heat Shock Factor 1 H4163 79245, 15499, 3297 HSF1,Hsf1 XP_001075095.1,NP_032322.1,NP_005517.1 P y y y
341 Heat Shock Factor 2 H6788 64441, 3298, 15500 HSF2,Hsf2 NP_113882.1,NP_004497.1,NP_032323.2 P y n/d